Acrospire Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,557
Closed -$42K 1383
2017
Q2
$42K Sell
2,557
-3,400
-57% -$55.8K 0.04% 1024
2017
Q1
$83K Sell
5,957
-16,730
-74% -$233K 0.07% 458
2016
Q4
$362K Buy
22,687
+12,793
+129% +$204K 0.15% 79
2016
Q3
$165K Buy
9,894
+1,516
+18% +$25.3K 0.11% 232
2016
Q2
$94K Sell
8,378
-3,822
-31% -$42.9K 0.07% 507
2016
Q1
$102K Buy
+12,200
New +$102K 0.07% 313